BIOCRYST PHARMACEUTICALS, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-03-31 was 202.00K shares, a 19.52% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-12-31 was 0.00 shares.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-09-30 was 161.00K shares, a 0.62% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-06-30 was 0.00 shares.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 369.00K shares, a 10.44% decline from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 412.00K shares, a 21.89% increase from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 338.00K shares, a 30.00% increase from fiscal 2022.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 260.00K shares, a 19.00% decline from fiscal 2021.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-12-31 | 369.00K shares 10-K · filed 2026-02-26 | |
| 2025-03-31 | 202.00K shares 10-Q · filed 2025-05-06 | 363.00K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 412.00K shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 161.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | 412.00K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 413.00K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 251.00K shares 10-Q · filed 2025-05-06 | 413.00K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 338.00K shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 162.00K shares 10-Q · filed 2023-11-08 | 338.00K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 321.00K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | 176.00K shares 10-Q · filed 2024-05-07 | 321.00K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 260.00K shares 10-K · filed 2025-02-25 |
| 2022-09-30 | 145.00K shares 10-Q · filed 2023-11-08 | 265.00K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 243.00K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 115.00K shares 10-Q · filed 2023-11-08 | 243.00K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 321.00K shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 123.00K shares 10-Q · filed 2022-11-04 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | |
| 2021-03-31 | 193.00K shares 10-Q · filed 2022-11-04 | |
| 2020-12-31 | 246.00K shares 10-K · filed 2023-02-27 | |
| 2019-12-31 | 115.00K shares 10-K · filed 2022-02-28 | |
| 2013-12-31 | 89.00K shares 10-K · filed 2014-03-10 | |
| 2012-12-31 | 110.00K shares 10-K · filed 2014-03-10 | |
| 2011-12-31 | 94.00K shares 10-K · filed 2014-03-10 | |
| 2010-12-31 | 51.00K shares 10-K · filed 2013-03-11 | |
| 2009-12-31 | 123.00K shares 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |